<p>(<b>A</b>) Displaying active site of the <i>Pv</i>PM-V Sal-1 (wild type) and its interaction with only known inhibitor lopinavir (red) (<b>B</b>) Displaying active site of the <i>Pv</i>PM-V-Ind (mutant) and its interaction with known inhibitor lopinavir (red). The docked lopinavir (red) showing interaction with hydrophobic amino acid residue (white) of the active site, while hydrophilic residues: acidic (red), Basic (blue) and neutral (green) comprise of the docking site. There are clear overall changes in structure as well as in interacting amino acids with the ligand.</p
<p>(A) The protein is depicted in surface view and ligand ZINC03984585 as stick in the binding pocke...
<p>The pictures on the left side are of LPL complexed with (a) CHEMBL339297, and (c) CHEMBL485946. T...
<p>(A) Saracatinib, (B) Isopraeroside IV, (C) 9HFG, and (D) aurantiamide. Hydrophobic interactions a...
<p>In panel A, hydrogen bond contacts are presented (dotted lines), which are formed between zanamiv...
<p>(<b>A</b>) <i>Pv</i>PM-V Sal-1 (Wild Type) (<b>B</b>) <i>Pv</i>PM-V-Ind (mutant). Displaying dock...
<p>Variations in the interacting amino acids speculates that a modulation in the activity of plasmep...
<p>(A) The crystallographic structure of PM4 protein in complex with the lopinavir as visualized usi...
<p>(A) 3D visualization of predicted drug binding to the DNA-binding domain (leucine zipper) of AP-1...
Homology modeling and docking methods were used to explore the effects of different mutants on antiv...
Protein recognition events are ubiquitous processes. This thesis work focuses on two proteins and th...
Four HIV-1 protease (PR) inhibitors, clinical inhibitors lopinavir and tipranavir, and two investiga...
<p>(A) Telaprevir bound to the wild-type protease with the substrate envelope in blue. Intra- and in...
<p>ZMR is shown as ribbon with purple color, and active site residues are colored in brown. Carbon, ...
Molecular recognition is a highly interdependent process. Subsite couplings within the active site o...
<p>(A)The protein is depicted in surface view and ligand ZINC08931589 as stick in the binding pocket...
<p>(A) The protein is depicted in surface view and ligand ZINC03984585 as stick in the binding pocke...
<p>The pictures on the left side are of LPL complexed with (a) CHEMBL339297, and (c) CHEMBL485946. T...
<p>(A) Saracatinib, (B) Isopraeroside IV, (C) 9HFG, and (D) aurantiamide. Hydrophobic interactions a...
<p>In panel A, hydrogen bond contacts are presented (dotted lines), which are formed between zanamiv...
<p>(<b>A</b>) <i>Pv</i>PM-V Sal-1 (Wild Type) (<b>B</b>) <i>Pv</i>PM-V-Ind (mutant). Displaying dock...
<p>Variations in the interacting amino acids speculates that a modulation in the activity of plasmep...
<p>(A) The crystallographic structure of PM4 protein in complex with the lopinavir as visualized usi...
<p>(A) 3D visualization of predicted drug binding to the DNA-binding domain (leucine zipper) of AP-1...
Homology modeling and docking methods were used to explore the effects of different mutants on antiv...
Protein recognition events are ubiquitous processes. This thesis work focuses on two proteins and th...
Four HIV-1 protease (PR) inhibitors, clinical inhibitors lopinavir and tipranavir, and two investiga...
<p>(A) Telaprevir bound to the wild-type protease with the substrate envelope in blue. Intra- and in...
<p>ZMR is shown as ribbon with purple color, and active site residues are colored in brown. Carbon, ...
Molecular recognition is a highly interdependent process. Subsite couplings within the active site o...
<p>(A)The protein is depicted in surface view and ligand ZINC08931589 as stick in the binding pocket...
<p>(A) The protein is depicted in surface view and ligand ZINC03984585 as stick in the binding pocke...
<p>The pictures on the left side are of LPL complexed with (a) CHEMBL339297, and (c) CHEMBL485946. T...
<p>(A) Saracatinib, (B) Isopraeroside IV, (C) 9HFG, and (D) aurantiamide. Hydrophobic interactions a...